66 related articles for article (PubMed ID: 8416447)
1. The "less than optimal" cytology: importance in obstetric patients and in a routine gynecologic population.
Kost ER; Snyder RR; Schwartz LE; Hankins GD
Obstet Gynecol; 1993 Jan; 81(1):127-30. PubMed ID: 8416447
[TBL] [Abstract][Full Text] [Related]
2. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
Zhao C; Austin RM
Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
[TBL] [Abstract][Full Text] [Related]
3. [Less pap-2 results ('minor abnormalities') in the population screening for cervical cancer since the introduction of new guidelines in 1996].
Bos AB; van Ballegooijen M; van den Akker-van Marle ME; Habbema JD
Ned Tijdschr Geneeskd; 2002 Aug; 146(34):1586-90. PubMed ID: 12224483
[TBL] [Abstract][Full Text] [Related]
4. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus detection: verification with cervical cytology.
Matthews-Greer J; Rivette D; Reyes R; Vanderloos CF; Turbat-Herrera EA
Clin Lab Sci; 2004; 17(1):8-11. PubMed ID: 15011974
[TBL] [Abstract][Full Text] [Related]
6. Repeating cytology at initial colposcopy does not improve detection of high-grade abnormalities: a retrospective cohort study of 6595 women.
Rieck GC; Bhaumik J; Beer HR; Leeson SC
Gynecol Oncol; 2006 May; 101(2):228-33. PubMed ID: 16325241
[TBL] [Abstract][Full Text] [Related]
7. Acetic acid visualization of the cervix to detect cervical dysplasia.
Van Le L; Broekhuizen FF; Janzer-Steele R; Behar M; Samter T
Obstet Gynecol; 1993 Feb; 81(2):293-5. PubMed ID: 8423967
[TBL] [Abstract][Full Text] [Related]
8. Prenatal and postpartum Pap smears: do we need both?
Londo R; Bjelland T; Girod C; Glasser M
Fam Pract Res J; 1994 Dec; 14(4):359-67. PubMed ID: 7863808
[TBL] [Abstract][Full Text] [Related]
9. The significance of atypical glandular cells on routine cervical cytologic testing in a community-based population.
Chin AB; Bristow RE; Korst LM; Walts A; Lagasse LD
Am J Obstet Gynecol; 2000 Jun; 182(6):1278-82. PubMed ID: 10871439
[TBL] [Abstract][Full Text] [Related]
10. Cervical changes associated with progestagen-only contraceptives: a team approach.
Darwish A; Labeeb S; Galal M; Rashad H; Hassan S
Contraception; 2004 Feb; 69(2):121-7. PubMed ID: 14759616
[TBL] [Abstract][Full Text] [Related]
11. Antepartum and postpartum Papanicolaou smears. Are they both necessary?
Jazayeri A; Heffron JA; Harnetty P; Jazayeri M; Gould SF
J Reprod Med; 1999 Oct; 44(10):879-82. PubMed ID: 10554750
[TBL] [Abstract][Full Text] [Related]
12. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors.
Sankaranarayanan R; Wesley R; Somanathan T; Dhakad N; Shyamalakumary B; Amma NS; Parkin DM; Nair MK
Cancer; 1998 Nov; 83(10):2150-6. PubMed ID: 9827719
[TBL] [Abstract][Full Text] [Related]
13. Significance of atypical repair in liquid-based gynecologic cytology: a follow-up study with molecular analysis for human papillomavirus.
Ng WK; Li AS; Cheung LK
Cancer; 2003 Jun; 99(3):141-8. PubMed ID: 12811854
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
Saraiya M; Irwin KL; Carlin L; Chen X; Jain N; Benard V; Montano DE
Cancer; 2007 Sep; 110(5):1024-32. PubMed ID: 17628488
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone.
Zhao C; Austin RM
Gynecol Oncol; 2007 Nov; 107(2):231-5. PubMed ID: 17854873
[TBL] [Abstract][Full Text] [Related]
16. Screening for cervical disease in mature women: strategies for improvement.
Colgan TJ; Clarke A; Hakh N; Seidenfeld A
Cancer; 2002 Aug; 96(4):195-203. PubMed ID: 12209660
[TBL] [Abstract][Full Text] [Related]
17. Neoplasia associated with atypical glandular cells of undetermined significance on cervical cytology.
Zweizig S; Noller K; Reale F; Collis S; Resseguie L
Gynecol Oncol; 1997 May; 65(2):314-8. PubMed ID: 9159344
[TBL] [Abstract][Full Text] [Related]
18. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
[TBL] [Abstract][Full Text] [Related]
19. HPV triage testing or repeat Pap smear for the management of atypical squamous cells (ASCUS) on Pap smear: is there evidence of process utility?
Howard K; Salkeld G; McCaffery K; Irwig L
Health Econ; 2008 May; 17(5):593-605. PubMed ID: 17764095
[TBL] [Abstract][Full Text] [Related]
20. The utility of human papillomavirus testing in the management of atypical glandular cells on cytology.
Sharpless KE; O'Sullivan DM; Schnatz PF
J Low Genit Tract Dis; 2009 Apr; 13(2):72-8. PubMed ID: 19387126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
